| P50 | author | Rocco Liguori | Q42735922 |
| | Patrizia Avoni | Q57312827 |
| P2093 | author name string | Silvana Franceschetti | |
| | Giuliano Avanzini | |
| P2860 | cites work | Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies | Q28213203 |
| | Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy | Q28216597 |
| | Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes | Q28236400 |
| | A calcium channel mutation causing hypokalemic periodic paralysis | Q28242375 |
| | A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis | Q28305953 |
| | Voltage-dependent calcium channel mutations in neurological disease. | Q33691500 |
| | Acetylcholine receptors and myasthenia | Q33862589 |
| | Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel | Q34091858 |
| | Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor | Q34204742 |
| | A new congenital non-progressive myopathy | Q34240624 |
| | Periodic paralysis: understanding channelopathies | Q34566685 |
| | Diphenylhydantoin Inhibition of Sodium Conductance in Squid Giant Axon | Q34714097 |
| | An expanding view for the molecular basis of familial periodic paralysis | Q34738564 |
| | Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism | Q36019333 |
| | Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome | Q39420128 |
| | Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder | Q40621263 |
| | The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels | Q40710947 |
| | Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. | Q40714401 |
| | Enhanced inactivation and pH sensitivity of Na(+) channel mutations causing hypokalaemic periodic paralysis type II. | Q40742646 |
| | Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block | Q40755711 |
| | Ion-channel defects and aberrant excitability in myotonia and periodic paralysis | Q41095963 |
| | Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels | Q43702724 |
| | Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes | Q44087155 |
| | QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin | Q44143225 |
| | Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures | Q44296252 |
| | Neurobiology of the Caenorhabditis elegans genome. | Q46229602 |
| | Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors | Q46931919 |
| | Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine | Q48112654 |
| | Calcium-dependent regulation of genetically determined spike and waves by the reticular thalamic nucleus of rats | Q48363147 |
| | Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones | Q48496496 |
| | Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. | Q48934070 |
| | Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture. | Q51743240 |
| | Spontaneous paroxysmal electroclinical patterns in rat: a model of generalized non-convulsive epilepsy. | Q53852193 |
| | Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia | Q55670933 |
| | Tonische Krämpfe in willkürlich beweglichen Muskeln in Folge von ererbter psychischer Disposition | Q56337929 |
| | Andersen's syndrome: A distinct periodic paralysis | Q57085845 |
| | KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel | Q22008501 |
| | Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 | Q22253421 |
| | A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy | Q24308706 |
| | Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias | Q24311437 |
| | Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease | Q24311805 |
| | A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns | Q24319094 |
| | A potassium channel mutation in neonatal human epilepsy | Q24320244 |
| | Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease | Q24336206 |
| | A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family | Q28115034 |
| | Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia | Q28142708 |
| | The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy | Q28142926 |
| | From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels | Q28143653 |
| | Ion channels and epilepsy | Q28189601 |
| | Sodium-channel defects in benign familial neonatal-infantile seizures | Q28202961 |
| | Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures | Q28207332 |
| | Molecular basis of an inherited epilepsy | Q28207595 |
| P433 | issue | 3 | |
| P921 | main subject | molecular biology | Q7202 |
| P304 | page(s) | 519-539 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Molecular biology of channelopathies: impact on diagnosis and treatment | |
| P478 | volume | 4 | |